COLISTIMETHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Colistimethate, and when can generic versions of Colistimethate launch?
Colistimethate is a drug marketed by Avet Lifesciences, Fresenius Kabi Usa, Nexus, Pharmobedient, Sagent Pharms Inc, and Xellia Pharms Aps. and is included in six NDAs.
The generic ingredient in COLISTIMETHATE is colistimethate sodium. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Colistimethate
A generic version of COLISTIMETHATE was approved as colistimethate sodium by FRESENIUS KABI USA on April 17th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COLISTIMETHATE?
- What are the global sales for COLISTIMETHATE?
- What is Average Wholesale Price for COLISTIMETHATE?
Summary for COLISTIMETHATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for COLISTIMETHATE |
| What excipients (inactive ingredients) are in COLISTIMETHATE? | COLISTIMETHATE excipients list |
| DailyMed Link: | COLISTIMETHATE at DailyMed |
US Patents and Regulatory Information for COLISTIMETHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 202359-001 | Sep 28, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 064216-001 | Feb 26, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 065364-001 | Apr 17, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
